| Period Ending | Mar 30, 2013 | Dec 30, 2012 | Sep 29, 2012 | Jun 29, 2012 |
|---|
|
Total Revenue
|
5,898,000
|
5,695,000
|
6,722,000
|
3,577,000
| | Cost of Revenue | 3,682,000 | 3,952,000 | 4,400,000 | 2,149,000 | | |
Gross Profit
|
2,216,000
|
1,743,000
|
2,322,000
|
1,428,000
| |
|
Operating Expenses |
|
Research Development |
-
|
-
|
-
|
-
|
|
Selling General and Administrative | 343,000 | 304,000 | 326,000 | 171,000 |
|
Non Recurring |
-
| (2,000) | 266,000 |
-
|
|
Others | 660,000 | 669,000 | 666,000 | 475,000 |
|
|
|
Total Operating Expenses |
-
|
-
|
-
|
-
| | | |
Operating Income or Loss
|
1,215,000
|
767,000
|
1,078,000
|
786,000
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | 82,000 | 129,000 | 146,000 | 73,000 |
|
Earnings Before Interest And Taxes | 1,331,000 | 931,000 | 1,243,000 | 895,000 |
|
Interest Expense | 367,000 | 385,000 | 401,000 | 232,000 |
|
Income Before Tax | 964,000 | 546,000 | 842,000 | 663,000 |
|
Income Tax Expense | 330,000 | 140,000 | 248,000 | 214,000 |
|
Minority Interest |
-
| (2,000) | (4,000) | (4,000) |
|
|
|
Net Income From Continuing Ops | 634,000 | 406,000 | 594,000 | 449,000 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
| 31,000 | 4,000 | (1,000) |
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | | |
Net Income
|
634,000
|
435,000
|
594,000
|
444,000
| | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | |
Net Income Applicable To Common Shares
|
634,000
|
435,000
|
594,000
|
444,000
|
|